Isradipine

伊拉地平

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameIsradipine
Drug Alias NameIsradipino依拉地平IsradipinumDynacirc CRDynacirc +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated L-type calcium channel
Therapy Area/IndicationsCravingSmokingSmoking Reduction +[9] 
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/12/20
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas At Austin
Inactive CompaniesUniversity Of RochesterSmithkline Beecham (Cork) LtdUniversity of Arkansas +[6] 
Active IndicationsCravingSmokingSmoking Reduction +[5] 
Inactive IndicationsOpioid-Related DisordersEssential HypertensionHypertension +[4] 

Other Information

ATC CodeC08CA03
Related LinksWikipediaDrugBankKEGG